A ‘right to try,’ but at what cost?
A few weeks ago, my colleague Stephanie Morain wrote a PolicyWise post on attempts to pass so-called “right-to-try” legislation in the U.S. House of Representatives.
Read MoreA few weeks ago, my colleague Stephanie Morain wrote a PolicyWise post on attempts to pass so-called “right-to-try” legislation in the U.S. House of Representatives.
Read MoreNot too long ago, I sat in a middle school biology classroom and read about Edward Jenner successfully using cowpox material to introduce immunity to
Read MoreOn March 6, the U.S. Food and Drug Administration (FDA) authorized 23andMe to expand its direct-to-consumer (DTC) genetic test to include selected variants in BRCA1
Read MoreMatch Day is finally here. For medical students seeking residency and fellowship training positions, this day is the culmination of years of studying and hard
Read MoreEditor’s note: This blog post is the second part of a two-part series. Read part one. We return to our case from the previous post: a same-sex
Read MoreEditor’s note: This blog post is the first part of a two-part series. The LA Times recently reported on a same-sex married couple who sought U.S.
Read MoreEarlier this month, six scholars working at the intersection of bioethics, pharmaceuticals, and law made national headlines for a letter sent to the House Energy
Read MoreIs death bad for the individual who dies? We’re inclined, I think, to answer that it is. Answering in the affirmative, however, raises another question:
Read MoreThe administration outlined a four-pillar approach to immigration in the Jan. 30 State of the Union, underscoring a commitment to establish a path to citizenship
Read MoreMary Shelley’s most famous novel, Frankenstein, turns 200 this year. In honor of this momentous anniversary, people across the country are celebrating the novel’s enduring
Read More